The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus

S Simon, O Joean, T Welte… - European Respiratory …, 2023 - Eur Respiratory Soc
Exacerbations of COPD are associated with worsening of the airflow obstruction,
hospitalisation, reduced quality of life, disease progression and death. At least 70% of …

[HTML][HTML] From co-infections to autoimmune disease via hyperactivated innate immunity: COVID-19 autoimmune coagulopathies, autoimmune myocarditis and …

R Root-Bernstein - International Journal of Molecular Sciences, 2023 - mdpi.com
Neutrophilia and the production of neutrophil extracellular traps (NETs) are two of many
measures of increased inflammation in severe COVID-19 that also accompany its …

[HTML][HTML] Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with …

J Sempere, M Llamosí, BL Ruiz, I Del Río… - The Lancet …, 2022 - thelancet.com
Background Epidemiological studies are necessary to explore the effect of current
pneumococcal conjugate vaccines (PCVs) against antibiotic resistance, including the rise of …

[HTML][HTML] Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2

E Mitsi, J Reiné, BC Urban, C Solórzano… - The Journal of …, 2022 - Am Soc Clin Investig
Background Although recent epidemiological data suggest that pneumococci may contribute
to the risk of SARS-CoV-2 disease, cases of coinfection with Streptococcus pneumoniae in …

Incidence and estimated vaccine effectiveness against hospitalizations for all-cause pneumonia among older US adults who were vaccinated and not vaccinated with …

A Hsiao, J Hansen, J Timbol, N Lewis… - JAMA network …, 2022 - jamanetwork.com
Importance Following routine use of 13-valent pneumococcal conjugate vaccine (PCV13) in
children in 2010, invasive pneumococcal disease rates have decreased substantially in …

Recombinant adjuvanted zoster vaccine and reduced risk of coronavirus disease 2019 diagnosis and hospitalization in older adults

KJ Bruxvoort, B Ackerson, LS Sy… - The Journal of …, 2022 - academic.oup.com
Background Some vaccines elicit nonspecific immune responses that may protect against
heterologous infections. We evaluated the association between recombinant adjuvanted …

Effectiveness of 13-valent pneumococcal conjugate vaccine against medically attended lower respiratory tract infection and pneumonia among older adults

JA Lewnard, KJ Bruxvoort, H Fischer… - Clinical Infectious …, 2022 - academic.oup.com
Background Among older adults, 13-valent pneumococcal conjugate vaccine (PCV13) has
been found efficacious against nonbacteremic pneumonia associated with vaccine-serotype …

[HTML][HTML] Community-acquired bacterial coinfections and COVID-19

MJ Patton, A Gaggar, M Might… - Physiological …, 2024 - journals.physiology.org
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the 29
causative pathogen of Coronavirus disease 2019 (COVID-19), has resulted in over 650 30 …

[HTML][HTML] Pneumococcal vaccination in adults: what can we learn from observational studies that evaluated PCV13 and PPV23 effectiveness in the same population?

EM Dunne, C Cilloniz, C von Mollendorf… - Archivos de …, 2023 - Elsevier
Introduction Fifteen and 20-valent pneumococcal conjugate vaccines (PCV15; PCV20) were
recently licensed to prevent pneumococcal disease in adults. In the absence of efficacy or …

Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Adults

AM Parker, N Jackson, S Awasthi, H Kim… - Clinical Infectious …, 2023 - academic.oup.com
Background Streptococcus pneumoniae interacts with numerous viral respiratory pathogens
in the upper airway. It is unclear whether similar interactions occur with severe acute …